Article Details

AstraZeneca COVID-19 jab developer Vaccitech sets IPO price

Retrieved on: 2021-04-26 12:22:30

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca COVID-19 jab developer Vaccitech sets IPO price. View article details on hiswai:

Excerpt

So far it has raised US$216mln from Gilead Sciences (NASDAQ:GILD), Sequoia Capital China and Oxford Sciences Innovation among others, ...

Article found on: www.proactiveinvestors.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up